The global Polymerase Chain Reaction (PCR) Technologies market is anticipated to grow at a considerable CAGR of around 5.7% during the forecast period.  The factors that are contributing to market growth include increasing in healthcare R&D expenditure, development of digital PCR technology benefited to cancer diagnostics and rising in the trend of self-diagnosis. Further, the advancement of molecular biology, forensic science, and genetic engineering are flourishing the growth of PCR market during the forecast period. Alternative technologies such as Nucleic Acid Sequence Based Amplification and Strand Displacement Amplification may hinder the market growth. The high cost of commercial PCR technology and next-generation sequencing are further expected to hamper the PCR market. 

PCR is a molecular diagnostic technology and allows better detection of diseases. Technological advancement is the evolution of digital PCR system and real-time PCR system and by this advancement; the PCR is becoming more efficient and user-friendly. Some challenges include the high cost of the instruments, reagents and servicing contract. Moreover, growing application in clinical diagnostics, application in drug development and increasing demand for personalized medicine and precision medicine are the factors that anticipating the growth of PCR market across the globe. 

Personalized medicine provides therapies to individual patients that depend on molecular disease. It provides better patient care; high safety margin and reduce healthcare cost. In the field of genetic medicine, the increasing demand for personalized medicine has created opportunities. For developing these opportunities, novel technologies must be incorporated. To gain an advantage in personalized medicine, the pharmaceutical firms and biotechnology are exploring consumer genetic testing and genomic medicine. The PCR has application in the molecular diagnostic of genetic diseases. It can detect genetic variation and predict response to various drugs. 

Impact of COVID-19 Pandemic on Global Polymerase Chain Reaction (PCR) Technologies Market 

COVID-19 has a positive impact on the global PCR technologies market. The PCR technologies market has experienced positive growth in terms of COVID-19 testing due to the positioning of PCR. The PCR is also a preferred technique, for cancer screening, its demand in cancer screening applications reported a sharp up gradation, owing to the availability of PCR testing tools.

 Segmental Outlook 

The global PCR technologies market is segmented on the basis of application, product, and end-user. Based on application, the market is segmented into Research Application, Clinical Diagnostics Application, Forensic Application, and Other Application. Based on products, the market is bifurcated into instruments, reagents and consumables, and software. PCR instruments include standard PCR system, digital PCR system, and RT PCR system. The reagents and consumables segment is significantly growing due to its high consumption, rising innovation in reagents specificity, and availability of the various type of tests which require different types of reagents. Based on end-user, the market is segmented into pharmaceutical and biotechnology industries, clinical diagnostics labs and hospitals and academic research organization.

Global Polymerase Chain Reaction (PCR) Technologies Market Share by End-User, 2021 (%)

Pharmaceutical and Biotechnology Industry is augmented to grow at the Fastest Rate in Global Polymerase Chain Reaction (PCR) Technologies Market

The pharmaceutical and biotechnology industry held the largest share in the PCR market due to continuous development in biotechnology industries has projected to the evolution of PCR techniques.  This technique has enabled scientist to identify genetic variation, gene expression and novel genes that have turn to the comparative analysis of diseases tissues.  Moreover, the sector's defensive qualities are underpinned by its strong innovation pipeline, combined with higher unmet medical needs, steady demand from growing and ageing populations and improving healthcare access globally. 

Regional Outlooks

The global polymerase chain reaction (pcr) technologies market is further segmented based on geography including North America (the US, and Canada Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America).  Asia-Pacific is expected to be the fastest-growing region mainly due to the increasing private and public investment in life science research, increasing patient population, advancement in technology and growing healthcare infrastructure in the emerging countries such as India and China.

Global Polymerase Chain Reaction (PCR) Technologies Market Growth, by Region 2021-2028

North America Region Dominated the Global Polymerase Chain Reaction (PCR) Technologies Market 

North America is significantly growing due to increasing demand for personalized medicine for chronic disease and growing efforts in early diagnosis of diseases are the factors drive the market. Furthermore, the rising of automated PCR instruments and higher purchasing power and affordability are projected to grow the PCR market. Moreover, the development and production of new vaccines, and drugs, expansion of the median age population, along with a major increased focus on attracting international and domestic players in the market, are further boosting the growth of the market. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in April 2021, Centene and Quest Diagnostics entered into a partnership to expand real-time reverse transcription polymerase chain reaction (RRT-PCR) Covid-19 testing across the US. Quest diagnostics conduct COVID-19 testing through its network of laboratories. The kit has been served was qualified by Federally Qualified Health Centers during the COVID-19 pandemic. 

Market Players Outlook

The major companies serving the global polymerase chain reaction (PCR) technologies market are Abbott laboratories, Inc., Agilent Technologies, Inc., F. Hoffmann-La Roche AG, Siemens AG, Thermo Fisher Scientific, Inc., Eppendorf AG,F. Hoffmann-La Roche AG,GE Healthcare, Illumina, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2021, Cipla Ltd., launched ‘ViraGen’, a polymerase chain reaction (COVID-19 Rt-PCR), test for COVID-19 with Ubio Biotechnology Systems Pvt. Ltd., in India. ViraGen is a real-time detection kit approved by the ICMR (Indian Council of Medical Research) and based on PCR technology. This test is designed for the qualitative detection of nucleic acid from SARS-CoV-2 in the upper and lower respiratory specimens from individuals suspected of COVID-19.

The Report Covers

• Market value data analysis of 2021 and forecast to 2028.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global polymerase chain reaction (pcr) technologies market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.